Show simple item record

dc.contributor.authorDutruel, Céline
dc.contributor.authorThole, Jelle
dc.contributor.authorGeels, Mark
dc.contributor.authorMollenkopf, Hans-Joachim
dc.contributor.authorOttenhoff, Tom
dc.contributor.authorGuzman, Carlos A
dc.contributor.authorFletcher, Helen A
dc.contributor.authorLeroy, Odile
dc.contributor.authorKaufmann, Stefan H E
dc.date.accessioned2015-06-30T13:40:51Zen
dc.date.available2015-06-30T13:40:51Zen
dc.date.issued2014-07-31en
dc.identifier.citationTRANSVAC workshop on standardisation and harmonisation of analytical platforms for HIV, TB and malaria vaccines: 'how can big data help?'. 2014, 32 (35):4365-8 Vaccineen
dc.identifier.issn1873-2518en
dc.identifier.pmid24950356en
dc.identifier.doi10.1016/j.vaccine.2014.06.014en
dc.identifier.urihttp://hdl.handle.net/10033/558698en
dc.description.abstractHigh-throughput analyses of RNA and protein expression are increasingly used for better understanding of vaccine-induced immunity and protection against infectious disease. With an increasing number of vaccine candidates in clinical development, it is timely to consider standardisation and harmonisation of sample collection, storage and analysis to ensure results of highest quality from these precious samples. These challenges were discussed by a group of international experts during a workshop organised by TRANSVAC, a European Commission-funded Research Infrastructure project. The main conclusions were: Platforms are rarely standardised for use in preclinical and clinical studies. Coordinated efforts should continue to harmonise the experimental set up of these studies, as well as the establishment of internal standards and controls. This will ensure comparability, efficiency and feasibility of the global analyses performed on preclinical and clinical data sets.
dc.language.isoenen
dc.relationinfo:eu-repo/grantAgreement/EC/FP7/241745en
dc.rightsopenAccessen
dc.subject.meshAIDS Vaccinesen
dc.subject.meshBiomedical Researchen
dc.subject.meshHumansen
dc.subject.meshMalaria Vaccinesen
dc.subject.meshTuberculosis Vaccinesen
dc.subject.meshVaccinationen
dc.titleTRANSVAC workshop on standardisation and harmonisation of analytical platforms for HIV, TB and malaria vaccines: 'how can big data help?'.en
dc.typeArticleen
dc.contributor.departmentHelmholtz Centre for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, Germany.en
dc.identifier.journalVaccineen
refterms.dateFOA2018-06-13T15:32:06Z
html.description.abstractHigh-throughput analyses of RNA and protein expression are increasingly used for better understanding of vaccine-induced immunity and protection against infectious disease. With an increasing number of vaccine candidates in clinical development, it is timely to consider standardisation and harmonisation of sample collection, storage and analysis to ensure results of highest quality from these precious samples. These challenges were discussed by a group of international experts during a workshop organised by TRANSVAC, a European Commission-funded Research Infrastructure project. The main conclusions were: Platforms are rarely standardised for use in preclinical and clinical studies. Coordinated efforts should continue to harmonise the experimental set up of these studies, as well as the establishment of internal standards and controls. This will ensure comparability, efficiency and feasibility of the global analyses performed on preclinical and clinical data sets.


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
Dutruel et al_final.pdf
Size:
437.4Kb
Format:
PDF
Description:
Open Access article

This item appears in the following Collection(s)

Show simple item record